You are here

Article info

Article menu

Download PDFPDF

Editorial
Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes
Free

Authors

  1. Correspondence to : Dr Joshua J Fenton
    , Department of Family and Community Medicine, The Center for Healthcare Policy and Research, University of California, Davis Health System, 4860 Y Street, Suite 2300, Sacramento, CA 95817, USA; jjfenton{at}ucdavis.edu
View Full Text

Citation

Fenton JJ
Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes
BMJ Evidence-Based Medicine 2016;21:81-82.

Publication history

  • Accepted April 3, 2016
  • First published April 21, 2016.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/